Welcome to the Future

The first wave of Generative AI was marked by rapid breakthroughs and bold experimentation. Tools like ChatGPT, Midjourney, and Gemini captured global attention and redefined what machines could create — from text and code to images and design concepts.

Every few years, the tech world collectively loses its mind. Investors pour in billions, founders spin grand narratives, and the media declares “the future is here.” And then…reality shows up.

In this engaging conversation, Lars Tvede, renowned author and investor, sits down with Hong Hao, economist and hedge fund manager, to discuss his latest book Hyperintelligence. Together, they explore how intelligence has evolved from the Big Bang to the rise of AI, what the coming wave of agentic systems and smart robots means for productivity and labor, and how these shifts may reshape global business cycles, markets, and investment opportunities.

Drug discovery is a notoriously long, expensive, and uncertain process. Bringing a single new therapy to market often takes 10–15 years and costs upwards of $2 billion, with most candidates failing somewhere along the way. But what if we could dramatically accelerate this process, lower costs, and identify promising drug candidates with far greater precision?

For years, quantum computing has been a buzzword floating somewhere between science fiction and laboratory experiments. But today, we’re entering a new phase: quantum technology is moving out of research labs and into early commercialization. That shift means businesses, policymakers, and investors can no longer afford to treat it as a distant curiosity.

The tech world moves fast. New innovations emerge daily, promising to revolution industries, improve productivity, or unlock untapped markets. But the excitement around emerging technologies often comes with a hidden cost: hype. Tech hype cycles—those peaks of inflated expectations followed by steep troughs of disillusionment—can trap companies into expensive missteps if they don’t approach them strategically.